Concepedia

Luc Cabel

LC

Statistics

Publications

42

Citations

2.1K

H-Index

25

Active since

2017

Affiliations

Institut Curie(Current)

Université Paris Cité

Inserm

Université de Versailles Saint-Quentin-en-Yvelines

Université Paris-Saclay

Luc Cabel is an author at Institut Curie specializing in medicine, pathology, and breast cancer.

ORCID

Top concepts

Publications per year

2017–2025

42

Publications

42

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Luc Cabel, Francesca Riva, Vincent Servois et al. · Annals of Oncology · 2017 · 336 citations

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué et al. · JAMA Oncology · 2020 · 168 citations · Full text

Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

Clarice S. Groeneveld, Jacqueline Fontugne, Luc Cabel et al. · European Journal of Cancer · 2021 · 141 citations

, , +10

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

François‐Clément Bidard, Nicolas Kiavué, Marc Ychou et al. · Cells · 2019 · 113 citations · Full text

Circulating Tumor Cells in Early Breast Cancer

Laura Thery, Alessandra Meddis, Luc Cabel et al. · JNCI Cancer Spectrum · 2019 · 101 citations · Full text

1–5 of 42